Serious Infection Risk from the Filgotinib Drug Development Program: Dr. James Galloway Save
Dr. Paul Studenic talks with Dr. James Galloway about abstract OP0126 presented at the virtual EULAR 2021 meeting.
Dr. Paul Studenic talks with Dr. James Galloway about abstract OP0126 presented at the virtual EULAR 2021 meeting.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.